Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients

Critical Care

Volumn 14, Issue 6, 2010, Pages

  Krishnan, Anand ^a   Ochola, Judith ^a   Mundy, Julie ^a   Jones, Mark ^a   Kruger, Peter ^a   Duncan, Emma ^a   Venkatesh, Bala ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b WESLEY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCITRIOL; CALCIUM ION; PARATHYROID HORMONE; VITAMIN D; BIOLOGICAL MARKER;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; FEMALE; FLUID SHIFT; HUMAN; INTENSIVE CARE UNIT; MALE; PARATHYROID HORMONE BLOOD LEVEL; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; ACUTE DISEASE; AGED; BLOOD; COMPARATIVE STUDY; CRITICAL ILLNESS; HEMODILUTION; MIDDLE AGED; PHYSIOLOGY; TIME; VITAMIN D DEFICIENCY;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CRITICAL ILLNESS; FEMALE; FLUID SHIFTS; HEMODILUTION; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78649330206     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9341     Document Type: Article

References (22)

1. Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 2009, 338:40-44. 10.1097/MAJ.0b013e3181aaee91, 2851242, 19593102.
2. Hamilton B. Vitamin D and human skeletal muscle. Scand J Med Sci Sports 2010, 20:182-190. 2860762, 19807897.
3. Krishnan A, Ochola J, Venkatesh B. Vitamin D in critical illness. Yearbook of Intensive Care and Emergency Medicine 2010, 273-81. Heidelberg: Springer-Verlag, Vincent JL.
4. Zittermann A, Schleithoff SS, Götting C, Fuchs U, Kuhn J, Kleesiek K, Tenderich G, Koerfer R. Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation 2009, 87:118-124. 10.1097/TP.0b013e31818c2708, 19136901.
5. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004, 62:60-65.
6. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
7. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637. 10.1001/archinte.168.15.1629, 2677029, 18695076.
8. Lee P, Nair P, Eisman JA, Center JR. Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality?. Intensive Care Med 2009, 35:2028-2032. 10.1007/s00134-009-1642-x, 19756497.
9. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouthers PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003, 88:4623-4632. 10.1210/jc.2003-030358, 14557432.
10. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 2008, 149:3656-3667. 10.1210/en.2008-0042, 2453093, 18372326.
11. Nierman DM, Mechanick JI. Bone hyperresorption is prevalent in chronically critically ill patients. Chest 1998, 114:954-955. 10.1378/chest.114.4.1122, 9792559.
12. Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. N Engl J Med 2009, 360:1912-1914. 10.1056/NEJMc0809996, 19403914.
13. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis occurrence in Acutely Ill Patients Investigators: sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34:344-353. 10.1097/01.CCM.0000194725.48928.3A, 16424713.
14. Morgan TJ, Venkatesh B, Hall J. Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution. Intensive Care Med 2004, 30:1432-1437. 10.1007/s00134-004-2176-x, 14991093.
15. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008, 88:582S-586S.
16. Edwards LJ, Muller KE, Wolfinger RD, Qaqish BF, Schabengerger O. An R2 statistic for fixed effects in the linear mixed model. Stat Med 2008, 27:6137-6157. 10.1002/sim.3429, 2587505, 18816511.
17. Reddy GS, Tserng KY. Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway. Biochemistry 1989, 28:1763-1769. 10.1021/bi00430a051, 2719932.
18. Brenza HL, Kimmel-Jehan C, Jehan F, Shinki T, Wakino S, Anazawa H, Suda T, DeLuca HF. Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. Proc Natl Acad Sci USA 1998, 95:1387-1391. 10.1073/pnas.95.4.1387, 19012, 9465024.
19. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001, 86:888-894. 10.1210/jc.86.2.888, 11158062.
20. Chun RF, Lauridsen AL, Suon L, Zella LA, Pike JW, Modlin RL, Martineau AR, Wilkinson RJ, Adams J, Hewison M. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 2010, 95:3368-3376. 10.1210/jc.2010-0195, 20427486.
21. Lucidarme O, Messai E, Mazzoni T, Arcade M, du Cheyron D. Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive Care Med 2010, 36:1609-1611. 10.1007/s00134-010-1875-8, 20373095.
22. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 2008, 45:153-159. 10.1258/acb.2007.007091, 18325178.